Skip to main content
Premium Trial:

Request an Annual Quote

MDL to Provide Discovery Informatics Systems to Nikem Research

NEW YORK, Dec. 3—MDL Information Systems announced Monday that it will provide software and informatics systems for NiKem Research Srl, the medicinal chemistry spinoff of GlaxoSmithKline’s former R&D center in Milan, Italy.

NiKem will use MDL’s applications in all stages of drug discovery research, including reagent selection, assay design and biological data capture, storage and analysis, chemical data searching, and chemical registration.

NiKem Research, which was formed in August 2001 by former SmithKline Beecham scientists, supplies services and products to the pharmaceutical industry. It is currently focused on lead optimization in pre-clinical drug development.

GlaxoSmithKline holds a minority equity stake in the company, and has a two-year contract with NiKem for lead optimization in treatments for neurology and respiratory diseases.

MDL Information Systems, based in San Leandro, Calif., is a subsidiary of Elsevier Science.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.